New research suggests GLP-1 drugs may improve liver and heart health even without major weight loss, reshaping how doctors ...

Dr. Josh Lindsley built Highland Longevity to focus on data, fitness, and sustainable health over quick fixes.

Hims & Hers stock is down ~40% YTD but remains a "Buy." Learn why compressed valuation and Eucalyptus-led Europe/Japan ...

Patients taking GLP-1 agonists before total joint arthroplasty experienced significantly higher rates of preoperative ...

Firms like Function Health and Oura market regular blood tests to people wanting to take their health into their own hands.

GLP-1 medications may not always work for weight loss. New research suggests that around 10% of people carry genetic ...

Use of GLP-1 receptor agonists continues to shift rapidly, with early April developments highlighting changes in pricing models, drug access, regulatory oversight and personalized care. Here are five ...

It's easy to see discarded plastic as nothing more than waste. Much of it ends up in landfill, breaking down into ...

Users claim synthetic proteins aid weight loss, anti-ageing and muscle repair, but concerns abound over regulation ...

A newly discovered molecule could reshape the future of weight loss treatments by mimicking the powerful appetite-suppressing ...

The addition of Foundayo expands LifeMD’s offerings of branded GLP-1 therapies from both Lilly and Novo Nordisk and reinforces LifeMD’s position as a leading destination for clinically guided weight ...

AUSTIN, Texas, April 9, 2026 /PRNewswire/ -- Choose Health, an at-home blood testing company specializing in liver and metabolic health, today announced the launch of the GLP-1 Health Monitoring ...